Nasdaq 100

REGN

Regeneron Pharmaceuticals, Inc., Health Care

$927.89

+13.33% on the day

Close of Fri, Oct 30, 2026

Your position

Bot consensus

77 long, 23 short

Most bots would own it.

Keenest to own it

See all 77

Keenest to short it

See all 23

Bot consensus

77 long, 23 short

Most bots would own it.

Keenest to own it

Ray Dalio100/100AskLong: #1 of 100 on Ray Dalio's long-minus-short score (0.554).
Benjamin Graham99/100AskLong: #2 of 100 on Benjamin Graham's long-minus-short score (0.572).
Kyle Bass99/100AskLong: #2 of 100 on Kyle Bass's long-minus-short score (0.584).

See all 77

Paul Tudor Jones99/100AskLong: #2 of 100 on Paul Tudor Jones's long-minus-short score (0.617).
Walter Schloss98/100AskLong: #3 of 100 on Walter Schloss's long-minus-short score (0.753).
Mohnish Pabrai96/100AskLong: #5 of 100 on Mohnish Pabrai's long-minus-short score (0.575).
Richard Dennis95/100AskLong: #6 of 100 on Richard Dennis's long-minus-short score (0.44).
James O'Shaughnessy94/100AskLong: #7 of 100 on James O'Shaughnessy's long-minus-short score (0.452).
Keith Gill93/100AskLong: #8 of 100 on Keith Gill's long-minus-short score (0.386).
Josh Peters92/100AskLong: #9 of 100 on Josh Peters's long-minus-short score (0.291).
Michael Burry92/100AskLong: #9 of 100 on Michael Burry's long-minus-short score (0.491).
Louis Bacon91/100AskLong: #10 of 100 on Louis Bacon's long-minus-short score (0.366).
Steve Kuhn91/100AskLong: #10 of 100 on Steve Kuhn's long-minus-short score (0.464).
Jeff Ubben90/100AskLong: #11 of 100 on Jeff Ubben's long-minus-short score (0.412).
Howard Marks89/100AskLong: #12 of 100 on Howard Marks's long-minus-short score (0.399).
Ken Griffin89/100AskLong: #12 of 100 on Ken Griffin's long-minus-short score (0.504).
Mario Gabelli89/100AskLong: #12 of 100 on Mario Gabelli's long-minus-short score (0.458).
Bill Ackman88/100AskLong: #13 of 100 on Bill Ackman's long-minus-short score (0.377).
Cliff Asness88/100AskLong: #13 of 100 on Cliff Asness's long-minus-short score (0.438).
Marc Cohodes88/100AskLong: #13 of 100 on Marc Cohodes's long-minus-short score (0.255).
Jesse Livermore87/100AskLong: #14 of 100 on Jesse Livermore's long-minus-short score (0.306).
Whitney Tilson87/100AskLong: #14 of 100 on Whitney Tilson's long-minus-short score (0.393).
Jim Chanos86/100AskLong: #15 of 100 on Jim Chanos's long-minus-short score (0.393).
John Paulson86/100AskLong: #15 of 100 on John Paulson's long-minus-short score (0.291).
Paul Singer86/100AskLong: #15 of 100 on Paul Singer's long-minus-short score (0.355).
Carson Block85/100AskLong: #16 of 100 on Carson Block's long-minus-short score (0.275).
John Templeton85/100AskLong: #16 of 100 on John Templeton's long-minus-short score (0.405).
Carl Icahn84/100AskLong: #17 of 100 on Carl Icahn's long-minus-short score (0.334).
Jim Simons84/100AskLong: #17 of 100 on Jim Simons's long-minus-short score (0.273).
David Dreman83/100AskLong: #18 of 100 on David Dreman's long-minus-short score (0.402).
Nate Anderson83/100AskLong: #18 of 100 on Nate Anderson's long-minus-short score (0.277).
David Einhorn82/100AskLong: #19 of 100 on David Einhorn's long-minus-short score (0.343).
Jeremy Grantham82/100AskLong: #19 of 100 on Jeremy Grantham's long-minus-short score (0.308).
Jeremy Siegel82/100AskLong: #19 of 100 on Jeremy Siegel's long-minus-short score (0.283).
Warren Buffett82/100AskLong: #19 of 100 on Warren Buffett's long-minus-short score (0.273).
Kevin O'Leary81/100AskLong: #20 of 100 on Kevin O'Leary's long-minus-short score (0.262).
Michael Price81/100AskLong: #20 of 100 on Michael Price's long-minus-short score (0.389).
John Maynard Keynes80/100AskLong: #21 of 100 on John Maynard Keynes's long-minus-short score (0.405).
Ken Fisher80/100AskLong: #21 of 100 on Ken Fisher's long-minus-short score (0.277).
Ed Thorp79/100AskLong: #22 of 100 on Ed Thorp's long-minus-short score (0.328).
Geraldine Weiss79/100AskLong: #22 of 100 on Geraldine Weiss's long-minus-short score (0.289).
Bill Fleckenstein78/100AskLong: #23 of 100 on Bill Fleckenstein's long-minus-short score (0.396).
Dan Loeb78/100AskLong: #23 of 100 on Dan Loeb's long-minus-short score (0.358).
Seth Klarman78/100AskLong: #23 of 100 on Seth Klarman's long-minus-short score (0.33).
Bill Miller77/100AskLong: #24 of 100 on Bill Miller's long-minus-short score (0.244).
David Shaw76/100AskLong: #25 of 100 on David Shaw's long-minus-short score (0.283).
Harry Markowitz76/100AskLong: #25 of 100 on Harry Markowitz's long-minus-short score (0.37).
Joel Greenblatt76/100AskLong: #25 of 100 on Joel Greenblatt's long-minus-short score (0.323).
Lowell Miller76/100AskLong: #25 of 100 on Lowell Miller's long-minus-short score (0.245).
Martin Shkreli76/100AskLong: #25 of 100 on Martin Shkreli's long-minus-short score (0.242).
Aswath Damodaran75/100AskLong: #26 of 100 on Aswath Damodaran's long-minus-short score (0.311).
Charlie Munger75/100AskLong: #26 of 100 on Charlie Munger's long-minus-short score (0.263).
John Neff75/100AskLong: #26 of 100 on John Neff's long-minus-short score (0.253).
Rob Arnott74/100AskLong: #27 of 100 on Rob Arnott's long-minus-short score (0.209).
Terry Smith74/100AskLong: #27 of 100 on Terry Smith's long-minus-short score (0.31).
Julian Robertson72/100AskLong: #29 of 100 on Julian Robertson's long-minus-short score (0.188).
Fama and French70/100AskLong: #31 of 100 on Fama and French's long-minus-short score (0.194).
Josh Brown70/100AskLong: #31 of 100 on Josh Brown's long-minus-short score (0.154).
Peter Lynch67/100AskLong: #34 of 100 on Peter Lynch's long-minus-short score (0.087).
Nicolas Darvas66/100AskLong: #35 of 100 on Nicolas Darvas's long-minus-short score (0.11).
Richard Driehaus66/100AskLong: #35 of 100 on Richard Driehaus's long-minus-short score (0.137).
Bruce Kovner65/100AskLong: #36 of 100 on Bruce Kovner's long-minus-short score (0.175).
Ed Seykota63/100AskLong: #38 of 100 on Ed Seykota's long-minus-short score (0.163).
Jim Cramer63/100AskLong: #38 of 100 on Jim Cramer's long-minus-short score (0.146).
Li Lu63/100AskLong: #38 of 100 on Li Lu's long-minus-short score (0.142).
Tom Gayner63/100AskLong: #38 of 100 on Tom Gayner's long-minus-short score (0.33).
William O'Neil63/100AskLong: #38 of 100 on William O'Neil's long-minus-short score (0.068).
Jim Rogers62/100AskLong: #39 of 100 on Jim Rogers's long-minus-short score (0.136).
George Soros59/100AskLong: #42 of 100 on George Soros's long-minus-short score (0.098).
Guy Spier59/100AskLong: #42 of 100 on Guy Spier's long-minus-short score (0.12).
Nelson Peltz59/100AskLong: #42 of 100 on Nelson Peltz's long-minus-short score (0.091).
Gerald Loeb57/100AskLong: #44 of 100 on Gerald Loeb's long-minus-short score (0.02).
Jeff Smith56/100AskLong: #45 of 100 on Jeff Smith's long-minus-short score (0.102).
Jack Bogle55/100AskLong: #46 of 100 on Jack Bogle's long-minus-short score (0.091).
Chuck Akre52/100AskLong: #49 of 100 on Chuck Akre's long-minus-short score (0.04).
Stanley Druckenmiller51/100AskLong: #50 of 100 on Stanley Druckenmiller's long-minus-short score (-0.031).
Bill Ruane48/100AskShort: #48 of 50 shorts on Bill Ruane's long-minus-short score (-0.009).

Keenest to short it

Fred Alger11/100AskShort: #12 of 50 shorts on Fred Alger's long-minus-short score (-0.515).
Cathie Wood13/100AskShort: #14 of 50 shorts on Cathie Wood's long-minus-short score (-0.426).
Chamath Palihapitiya13/100AskShort: #14 of 50 shorts on Chamath Palihapitiya's long-minus-short score (-0.508).

See all 23

Nick Sleep24/100AskShort: #25 of 50 shorts on Nick Sleep's long-minus-short score (-0.149).
Ron Baron26/100AskShort: #27 of 50 shorts on Ron Baron's long-minus-short score (-0.278).
Brad Gerstner27/100AskShort: #28 of 50 shorts on Brad Gerstner's long-minus-short score (-0.285).
Michael Steinhardt27/100AskShort: #28 of 50 shorts on Michael Steinhardt's long-minus-short score (-0.145).
Chase Coleman28/100AskShort: #29 of 50 shorts on Chase Coleman's long-minus-short score (-0.244).
Dennis Lynch28/100AskShort: #29 of 50 shorts on Dennis Lynch's long-minus-short score (-0.21).
Mark Minervini30/100AskShort: #31 of 50 shorts on Mark Minervini's long-minus-short score (-0.18).
Thomas Russo30/100AskShort: #31 of 50 shorts on Thomas Russo's long-minus-short score (-0.167).
Will Danoff35/100AskShort: #36 of 50 shorts on Will Danoff's long-minus-short score (-0.114).
Mark Cuban41/100AskShort: #42 of 50 shorts on Mark Cuban's long-minus-short score (-0.09).
T. Rowe Price42/100AskShort: #43 of 50 shorts on T. Rowe Price's long-minus-short score (-0.073).
Gerald Tsai43/100AskShort: #44 of 50 shorts on Gerald Tsai's long-minus-short score (-0.081).
Nancy Pelosi (household)43/100AskShort: #44 of 50 shorts on Nancy Pelosi (household)'s long-minus-short score (-0.112).
Steve Cohen43/100AskShort: #44 of 50 shorts on Steve Cohen's long-minus-short score (0.007).
Martin Zweig44/100AskShort: #45 of 50 shorts on Martin Zweig's long-minus-short score (-0.056).
Philippe Laffont46/100AskShort: #46 of 50 shorts on Philippe Laffont's long-minus-short score (-0.006).
Philip Fisher49/100AskShort: #49 of 50 shorts on Philip Fisher's long-minus-short score (-0.035).
Linda Raschke50/100AskShort: #50 of 50 shorts on Linda Raschke's long-minus-short score (-0.008).
Peter Thiel50/100AskShort: #50 of 50 shorts on Peter Thiel's long-minus-short score (0.004).
Dave Portnoy52/100AskLong: #49 of 100 on Dave Portnoy's long-minus-short score (0.032).

Modeled on each investor's published approach, not their real picks. Ask opens a chat with that bot about REGN in Claude or ChatGPT. Connect your assistant →

Stock of the Day

It hasn't been the Stock of the Day yet.

+22.4% over 1M

2026-09-302026-10-152026-10-30

Market cap$95.5B

Last close$927.89

Day move+13.33%

SectorHealth Care

About

Biotechnology, 15,410 employees

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions.

From Yahoo Finance, regeneron.com

About

Loading the company profile…

Fundamental analysis

Is Regeneron Pharmaceuticals Inc a Buy? | Full Deep Dive | REGN Analysis | StokTokStockTok , Thu, Apr 30

Picked by YouTube search, not by us. Someone else's view, not advice.

Earnings

Source: Nasdaq and Zacks consensus

Beat the forecast in 4 of the last 4 quarters.

Jun 2026, Jul 30Beat+56.6%EPS $12.53 vs $8.00 expectedStock +9.7% around it
Mar 2026, Apr 29Beat+19.4%EPS $7.50 vs $6.28 expectedStock −3.4% around it
Dec 2025, Jan 30Beat+12.3%EPS $9.30 vs $8.28 expectedStock +0.7% around it
Sep 2025, Oct 28Beat+28.1%EPS $9.63 vs $7.52 expectedStock +11.5% around it

The stock's move is from the close before the report to the close after it.

Earnings

Loading past results…

Financials

Last 8 quarters

Quarter ending	Jun 2026	Mar 2026	Dec 2025*	Sep 2025	Jun 2025	Mar 2025	Dec 2024*	Sep 2024
Revenue	$4.3B	$3.6B	$3.9B	$3.8B	$3.7B	$3.0B	$3.8B	$3.7B
Gross margin	—	—	—	—	—	—	—	—
Operating margin	30.1%	17.8%

How it ranks in the 100

0 = last, 100 = first

CheapEarnings, book value, cash flow vs price80
GrowingRevenue and earnings growth15
QualityHigh return on equity, fat margins, little debt69
TrendPast year, skipping last month53
PayoutsDividends and buybacks71
Big

Research

REGN in numbers and news

Valuation

Source: SEC filings and daily closes

Loading the next results date…

P/E22.7price ÷ last 12 months' earnings

EPS$40.84earnings a share, 12 months

Revenue growth+1.0%last fiscal year over the one before

Dividend yield0.51%paid over the past year, at today's price

52-week range$600.66–$927.89lowest to highest close

Beta0.19a year against the Nasdaq 100's average stock; 1 moves with it

Valuation

Loading figures…

Insider trades

Insider trades are unavailable right now. Try again later.

Insider trades

Loading insider trades…

Insider trades

Insider trades are unavailable right now. Try again later.

Insider trades

Loading insider trades…

In the news

Headlines are the outlets' views, not ours. Read the date before the headline. More on Yahoo Finance

In the news

Loading headlines…

In the news

Headlines are the outlets' views, not ours. Read the date before the headline. More on Yahoo Finance

In the news

Loading headlines…

Figures from SEC filings and daily closes; results dates and headlines from Yahoo Finance and Nasdaq; insider trades from SEC Form 4. For learning, not investment advice.

Discussion

No posts on REGN yet. Make the first case for it, or against it.

Discussion

Loading players’ posts…

Measure	REGN	Higher than
Earnings yield (earnings ÷ price)	4.4%	70%
Book yield (book value ÷ price)	32.2%	83%
Free cash flow yield	5.1%	75%
Buyback yield	3.5%	88%
Revenue growth, a year	1.0%	11%
EPS growth, a year	8.2%	44%
Return on equity	13.7%	34%
Return on assets	10.4%	55%
Net margin	27.9%	76%
Liabilities ÷ assets	24.0%	12%
Past year, skipping last month	13.1%	53%
Past 6 months, skipping last month	5.0%	56%
Volatility, a year's worth	37.6%	49%

About

About

Fundamental analysis

Earnings

Earnings

Financials

How it ranks in the 100

REGN in numbers and news

Valuation

Valuation

Insider trades

Insider trades

Insider trades

Insider trades

In the news

In the news

In the news

In the news

Discussion

Discussion

The figures behind them

Fundamental analysis

In the news

About

Valuation

Discussion

Earnings

In the news

Insider trades

Insider trades